Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
Clinical trial NCT01133275 · COMPLETED
Trial details
- NCT number
- NCT01133275
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-28
- Primary completion
- 2015-01-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.